clofibrate has been researched along with gamma-butyrobetaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eder, K; Hirche, F; Pösel, S; Ringseis, R | 1 |
| Eder, K; Fischer, M; Geissler, S; Hirche, F; Kluge, H; Luci, S; Ringseis, R; Spielmann, J; Wen, G | 1 |
2 other study(ies) available for clofibrate and gamma-butyrobetaine
| Article | Year |
|---|---|
Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
Topics: Acyl-CoA Oxidase; Aldehyde-Lyases; Animals; Betaine; Carnitine; Carnitine O-Palmitoyltransferase; Clofibrate; Cytochrome P-450 CYP4A; gamma-Butyrobetaine Dioxygenase; Hypolipidemic Agents; Intestine, Small; Liver; Lysine; Male; Muscle, Skeletal; Organic Cation Transport Proteins; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger; Solute Carrier Family 22 Member 5; Up-Regulation | 2007 |
Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species.
Topics: Animals; Betaine; Body Weight; Carnitine; Clofibrate; Eating; Enterocytes; gamma-Butyrobetaine Dioxygenase; Gene Expression; Homeostasis; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Organic Cation Transport Proteins; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Swine; Tissue Distribution; Up-Regulation | 2008 |